Dow Jones

38 834,86

0,15%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Avexis, Inc. (delisted) (AVXS)
Avexis, Inc. (delisted) (AVXS) Actualités

AVXS

AVEXIS, INC. (AVXS)

Avexis, Inc. (delisted)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:AVXS

1 2 3 4 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
11/06/2018	16h01	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
06/06/2018	17h04	Edgar (US Regulatory)	Confidential Treatment Order (ct Order)	NASDAQ:AVXS	Avexis, Inc. (delisted)
04/06/2018	23h25	Edgar (US Regulatory)	Termination of Registration of a Class of Security Under Section 12(b) (15-12b)	NASDAQ:AVXS	Avexis, Inc. (delisted)
23/05/2018	12h02	Edgar (US Regulatory)	Notice of Effectiveness (effect)	NASDAQ:AVXS	Avexis, Inc. (delisted)
17/05/2018	17h49	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	18h51	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	18h44	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	18h34	Edgar (US Regulatory)	Post-effective Amendment to an S-8 Filing (s-8 Pos)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	18h32	Edgar (US Regulatory)	Post-effective Amendment to Registration Statement (pos Am)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	18h21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	15h04	Edgar (US Regulatory)	(25-NSE)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13h28	Edgar (US Regulatory)	Amended Statement of Ownership: Solicitation (sc 14d9/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
15/05/2018	13h04	Edgar (US Regulatory)	Amended Tender Offer Statement by Third Party (sc To-t/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
04/05/2018	23h10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:AVXS	Avexis, Inc. (delisted)
03/05/2018	22h01	GlobeNewswire Inc.	AveXis Reports First Quarter 2018 Financial and Operating Results	NASDAQ:AVXS	Avexis, Inc. (delisted)
02/05/2018	15h27	GlobeNewswire Inc.	AveXis Provides Update on Proposed Acquisition by Novartis AG	NASDAQ:AVXS	Avexis, Inc. (delisted)
30/04/2018	23h26	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:AVXS	Avexis, Inc. (delisted)
25/04/2018	14h00	GlobeNewswire Inc.	AveXis Announces First Patient Dosed in Phase 3 Trial of AVXS-101 in Pre-Symptomatic SMA Types 1, 2 and 3	NASDAQ:AVXS	Avexis, Inc. (delisted)
24/04/2018	22h01	GlobeNewswire Inc.	AveXis Presents Initial Data from Pivotal U.S. Trial for SMA Type 1 and 24-Month Follow-Up Data from Phase 1 Trial of AVXS-10...	NASDAQ:AVXS	Avexis, Inc. (delisted)
20/04/2018	17h51	Edgar (US Regulatory)	Statement of Beneficial Ownership (sc 13d)	NASDAQ:AVXS	Avexis, Inc. (delisted)
19/04/2018	14h00	GlobeNewswire Inc.	AveXis to Present AVXS-101 Data at the Annual Meeting of the American Academy of Neurology	NASDAQ:AVXS	Avexis, Inc. (delisted)
17/04/2018	22h29	Edgar (US Regulatory)	Statement of Ownership: Solicitation (sc 14d9)	NASDAQ:AVXS	Avexis, Inc. (delisted)
17/04/2018	22h28	Edgar (US Regulatory)	Tender Offer Statement by Third Party (sc To-t)	NASDAQ:AVXS	Avexis, Inc. (delisted)
11/04/2018	23h41	PR Newswire (US)	WEISSLAW LLP Investigates AveXis Inc. Acquisition	NASDAQ:AVXS	Avexis, Inc. (delisted)
10/04/2018	22h49	Edgar (US Regulatory)	Written Communication Relating to an Issuer or Third Party (sc To-c)	NASDAQ:AVXS	Avexis, Inc. (delisted)
10/04/2018	09h02	Dow Jones News	Novartis Deal to Help Drug Pipeline -- WSJ	NASDAQ:AVXS	Avexis, Inc. (delisted)
10/04/2018	09h02	Dow Jones News	What's News: Business & Finance -- WSJ	NASDAQ:AVXS	Avexis, Inc. (delisted)
09/04/2018	23h28	Edgar (US Regulatory)	Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)	NASDAQ:AVXS	Avexis, Inc. (delisted)
09/04/2018	18h59	Dow Jones News	Gene-Therapy Stocks Get Boost as Analysts Speculate Novartis' Next Target -- Market Mover	NASDAQ:AVXS	Avexis, Inc. (delisted)
09/04/2018	18h00	Dow Jones News	Novartis Buying AveXis for $8.7 Billion -- Deal Digest	NASDAQ:AVXS	Avexis, Inc. (delisted)